Sign in to view content

Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy

Michael J Allingham, MD, PhD

Video
Published 2022

Related

Outcomes of Eyes Lost to Follow-up After Treatment With Intraocular and Periocular Steroid Injections
John W Hinkle, MD
On Demand Cases, Courses, and Papers
2021
Incidence of New Diabetic Macular Edema in Fellow Eyes of Patients in the VISTA and VIVID Studies
Sumit Sharma, MD, FASRS
Annual Meeting Talks
2020
Imaging, Digital, Angiography Symposium 1
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more